BRADYKININ IN CARCINOID-SYNDROME

被引：19

作者：

GUSTAFSEN, J ^{[1
]}

BOESBY, S ^{[1
]}

NIELSEN, F ^{[1
]}

GIESE, J ^{[1
]}

机构：

[1] GLOSTRUP HOSP,DEPT CLIN PHYSIOL,DK-2600 GLOSTRUP,DENMARK

来源：

GUT | 1987年 / 28卷 / 11期

关键词：

D O I：

10.1136/gut.28.11.1417

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1417 / 1419

页数：3

共 23 条

[11]

NIELSEN F, 1983, ACTA MED SCAND S677, V214, P54

[12] DOUBLE-ANTIBODY SOLID-PHASE RADIOIMMUNOASSAY FOR BLOOD BRADYKININ [J].

NIELSEN, MD ;

NIELSEN, F ;

KAPPELGAARD, AM ;

GIESE, J .

CLINICA CHIMICA ACTA, 1982, 125 (02) :145-156

[13] ANTISERA RAISED AGAINST ELEDOISIN AND KASSININ DETECT ELEVATED LEVELS OF IMMUNOREACTIVE MATERIAL IN PLASMA AND TUMOR-TISSUES FROM PATIENTS WITH CARCINOID-TUMORS [J].

NORHEIM, I ;

THEODORSSONNORHEIM, E ;

BRODIN, E ;

OBERG, K ;

LUNDQVIST, G ;

ROSELL, S .

REGULATORY PEPTIDES, 1984, 9 (04) :245-257

[14]

Oates J A, 1967, Adv Pharmacol, V5, P109, DOI 10.1016/S1054-3589(08)60656-0

[15] EVIDENCE FOR RELEASE OF BRADYKININ IN CARCINOID SYNDROME [J].

OATES, JA ;

PETTINGER, WA ;

DOCTOR, RB .

JOURNAL OF CLINICAL INVESTIGATION, 1966, 45 (02) :173-+

[16]

OATES JA, 1964, LANCET, V1, P514

[17]

REGOLI D, 1980, PHARMACOL REV, V32, P1

[18]

ROBERTSON JIS, 1962, Q J MED, V31, P103

[19]

SANDLER M, 1968, LANCET, V2, P1053

[20]

SHIMAMOTO K, 1982, ENDOCRINOL JAPON, V29, P487

← 1 2 3 →